Purpose of the Bill

The purpose of this bill is to extend the prohibition on drug manufacturers from interfering with access to 340B drugs by repealing the expiration of the relevant statute.

Main Provisions

• Repealing Expiration Date: The bill repeals the expiration provision in the Minnesota Statutes Section 62J.96, Subdivision 3, which means the prohibition on manufacturers interfering with access to 340B drugs will no longer expire on July 1, 2027.

Significant Changes

• By removing the expiration clause, the prohibition will remain in effect indefinitely, ensuring continued access to 340B drugs without interference from drug manufacturers.

Relevant Terms

• Drug manufacturers
• 340B drugs
• Access
• Interference
• Prohibition
• Expiration repeal